CE-25PA1009X - The Changing Landscape of Schizophrenia Treatment—Where Are We Now?
This continuing pharmacy education activity provides a comprehensive update on the evolving treatment strategies for schizophrenia. Key topics include current consensus guidelines, comparisons of newly approved antipsychotic therapies, updates to REMS programs—particularly clozapine—and emerging long-acting injectable options. The presentation also explores novel agents and discusses practical approaches to medication management, adverse effect monitoring, and improving adherence. Designed for pharmacy professionals, this session emphasizes evidence-based decision-making and patient-centered care in managing schizophrenia.
Course Outline
Speaker and Disclosure
Speaker
Emma Palmer, PharmD, BCPS, BCPP
Professor, Clinical and Administrative Sciences, University of Cincinnati James L Winkle College of Pharmacy.
Disclosure
The speaker and planning committee members have no relevant financial relationships with ineligible companies to disclose.
Learner Outcomes
Pharmacists who complete the course can expect the following learning outcomes:
1. Recall current consensus recommendations for the management of schizophrenia.
2. Compare new products approved for schizophrenia treatment.
3. Discuss important updates to schizophrenia-related REMS programs.
4. Formulate a plan for appropriate medication management of an individual with schizophrenia.
Who Should Register?
Pharmacists who want to stay current on evidence-based, patient-centered approaches to managing schizophrenia should register for this course.
Additional Information
Requirements:
Credit requirements must be completed before the expiration date of the activity. Participants must watch the video in its entirety and completion of a post-test with a score of 80% or higher. Upon completion, credit will be transmitted electronically to the ACPE. All transmitted credit will be viewable in your CPE Monitor profile within 24 hours. It is the participants' responsibility to ensure credit is properly populating on their individual NABP eProfile account. Please contact the James L. Winkle College of Pharmacy Continuing Pharmacy Education Office at (513) 558-4716 or RxCPD@uc.edu with questions or concerns.
The Office of Continuing Pharmacy Education has a formal grievance process to address any problems related to this activity or its administration. (Effective January 2008) Comments and/or concerns about this activity should be sent to the University of Cincinnati James L. Winkle College of Pharmacy, 3255 Eden Ave., Cincinnati, OH 45267-0004, Attention: Dr. Karissa Kim. Questions about Continuing Pharmacy Education credit may be forwarded to this address. The CPE Office can be reached at (513) 558-4716 or via email at RxCPD@UC.edu.
|
Minimum System Requirements
Processor: 1 GHz
Hard Drive: 32 GB
Memory (RAM): 1 GB
Sound card w/speakers
Internet Access: 10 Mbps download
|
Supported Browsers
Latest Chrome Version
Lastest Firefox Version
Lastest Edge Version
Lastest Safari Version
Internet Explorer 11
|
Select a section to register
The University of Cincinnati James L. Winkle College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.